Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-24

Clinical Trial Update: Study for Prevent Chronification Migraine Through Prediction of Response to Treatment With Anti-CGRP Antibodies

View source ↗

Summary

A clinical trial is investigating whether forecasting response to anti-CGRP antibody treatment can prevent chronification in migraine, with recruitment currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anti-CGRP antibodies (calcitonin gene-related peptide antibodies)

Snippet

Sponsor: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Conditions: Migraine | Status: RECRUITING